United Therapeutics Corp (Nasdaq: UTHR) announced that its Board of Directors authorized the repurchase of up to an additional $500 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE